Modes of failure of Trifecta aortic valve prosthesis.
Aortic valve
Aortic valve prosthesis
Aortic valve replacement
Journal
Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399
Informations de publication
Date de publication:
09 07 2022
09 07 2022
Historique:
received:
10
02
2022
accepted:
23
03
2022
pubmed:
30
3
2022
medline:
22
7
2022
entrez:
29
3
2022
Statut:
ppublish
Résumé
Several concerns have been recently raised regarding the durability of Trifecta prostheses. Different mechanisms of early failure were reported. Our aim was to study in a large population the modes of failure of Trifecta valves. We conducted a retrospective analysis of patients who underwent surgical aortic valve replacement with a Trifecta prosthesis during the period 2010-2018. Details regarding the mode of failure and haemodynamic dysfunction were collected for patients who underwent reintervention for structural valve failure. The Kaplan-Meier method was used to calculate survival. Competing risk analysis was performed to calculate the cumulative risk of reintervention for structural valve failure. The overall population comprises 1228 patients (1084 TF model and 144 TFGT model). Forty-four patients-mean patients' age at the time of the first implant 69 (standard deviation: 12) years and 61% female-underwent reintervention for structural valve failure after a median time of 63 [44-74] months. The cumulative incidence of reintervention for structural valve failure was 0.16% (SE 0.11%), 1.77% (SE 0.38%) and 5.11% (SE 0.98%) at 1, 5 and 9 years, respectively. In 24/44 patients (55%), a leaflet tear with dehiscence at the commissure level was found intraoperatively or described by imaging assessment. The cumulative incidence of reintervention for failure due to leaflet(s) tear was 0.16% (SE 0.11%), 1.08% (SE 0.29%) and 3.03% (SE 0.88%) at 1, 5 and 9 years, respectively. Leaflet(s) tear with dehiscence along the stent post was the main mode of early failure, up to 5 years, after Trifecta valves' implantation.
Identifiants
pubmed: 35348698
pii: 6554752
doi: 10.1093/icvts/ivac086
pmc: PMC9297516
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
Références
Ann Thorac Surg. 2021 Apr;111(4):1198-1205
pubmed: 33011168
Ann Thorac Surg. 2020 Mar;109(3):720-727
pubmed: 31398357
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):408-417
pubmed: 28874031
JTCVS Tech. 2020 Aug 12;4:106-108
pubmed: 34317979
Interact Cardiovasc Thorac Surg. 2021 Jan 1;32(1):39-46
pubmed: 33221889
J Thorac Cardiovasc Surg. 2017 Jan;153(1):21-28.e1
pubmed: 27697360
Ann Thorac Surg. 2019 Aug;108(2):e87-e89
pubmed: 30684483
J Thorac Cardiovasc Surg. 2019 Oct;158(4):1032-1039
pubmed: 30635187
Ann Thorac Surg. 2021 Nov;112(5):1424-1431
pubmed: 33338482
Ann Thorac Surg. 2020 Jan;109(1):86-92
pubmed: 31336064
Interact Cardiovasc Thorac Surg. 2015 Feb;20(2):281-2
pubmed: 25404230
J Thorac Cardiovasc Surg. 2017 Oct;154(4):1235-1240
pubmed: 28610762
Ann Thorac Surg. 2011 Nov;92(5):1621-7
pubmed: 21944438
Ann Thorac Surg. 2017 Jun;103(6):1933-1939
pubmed: 27955900
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):272-278
pubmed: 28430883
Ann Thorac Cardiovasc Surg. 2017 Jun 20;23(3):157-160
pubmed: 27980283
Clin Case Rep. 2020 Nov 28;9(1):286-290
pubmed: 33489175
Ann Thorac Surg. 2020 Sep;110(3):879-888
pubmed: 32061588
Interact Cardiovasc Thorac Surg. 2020 Mar 1;30(3):417-423
pubmed: 31778161